Not exact matches
Paul Black lists out three big trends to watch for in
health IT this year, namely: a continuing shift to value - based
care models (rather than the fee - for - service, volume - oriented paradigm which still dominates the sector); digital
health infrastructure interoperability that makes it possible for different systems to talk to each other and coordinate
care; and an increased focus on
precision medicine and «genomically aware
care» that can help take a lot of the guesswork out of medicine.
Background: President Obama first announced the program back in 2015 to realize the dream of
precision medicine — that is, tailoring
health care to an individual's genetics, lifestyle, and environment.
Tempus is a
precision medicine company that uses a machine learning
health care data analytics platform to enable physicians to deliver personalized
care to cancer patients.
Collins called the project a «cornerstone» of
precision medicine: «The goal here is to be the foundation for almost everything you want to know about future individualized
care and improved
health.»
The CER movement, which centers on the need to contain
health care costs while maintaining quality, combines mathematical
precision with political sensitivities to evaluate how medical treatments work in the real world.
On Dec. 1 - 2, those issues will come to the fore as national experts in genetics, medicine, law, big data and other fields gather for Frontiers in
Precision Medicine II: Cancer, Big Data and the Public, a unique
precision medicine symposium at the University of Utah S.J. Quinney College of Law, Center for Law and Biomedical Sciences, University of Utah
Health Sciences, Huntsman Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER) addresses those topics as precision medicine is gaining more attention nationwide from health care systems, practitioners, researchers, insurers and federal age
Health Sciences, Huntsman Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER) addresses those topics as
precision medicine is gaining more attention nationwide from
health care systems, practitioners, researchers, insurers and federal age
health care systems, practitioners, researchers, insurers and federal agencies.
Two new
precision medicine tests that look beyond cancer genes to identify novel therapeutic targets have just received New York State Department of
Health approval and are now available to both oncologists and cancer researchers for use at the front lines of patient
care.
LOS ANGELES, Calif. & BOSTON, Mass. — Scientists at Cedars - Sinai and Emulate, Inc. are pioneering a Patient - on - a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant — a new approach to
precision medicine for improving patient
care and
health.
To realise the potential of personalised
health -
care and
precision medicine, it's essential to have reliable, consistent and secure personal
health data.
Stanford, CA About Blog Stanford Medicine is leading the biomedical revolution in
precision health, defining and developing the next generation of
care.